Your browser doesn't support javascript.
loading
Association of Somatic Driver Alterations With Prognosis in Postmenopausal, Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: A Secondary Analysis of the BIG 1-98 Randomized Clinical Trial.
Luen, Stephen J; Asher, Rebecca; Lee, Chee Khoon; Savas, Peter; Kammler, Roswitha; Dell'Orto, Patrizia; Biasi, Olivia Maria; Demanse, David; JeBailey, Lellean; Dolan, Sinead; Hackl, Wolfgang; Thuerlimann, Beat; Viale, Giuseppe; Colleoni, Marco; Regan, Meredith M; Loi, Sherene.
Afiliación
  • Luen SJ; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.
  • Asher R; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.
  • Lee CK; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.
  • Savas P; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.
  • Kammler R; International Breast Cancer Study Group, Coordinating Center, Central Pathology Office, Bern, Switzerland.
  • Dell'Orto P; International Breast Cancer Study Group, Central Pathology Office, Department of Pathology, European Institute of Oncology, Milan, Italy.
  • Biasi OM; Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy.
  • Demanse D; Novartis Pharma AG, Basel, Switzerland.
  • JeBailey L; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Dolan S; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Hackl W; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Thuerlimann B; Breast Center, Cantonal Hospital, St Gallen, Switzerland.
  • Viale G; International Breast Cancer Study Group Central Pathology Office, European Institute of Oncology, University of Milan, Milan, Italy.
  • Colleoni M; Division of Medical Senology, European Institute of Oncology, Milan, Italy.
  • Regan MM; Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Loi S; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.
JAMA Oncol ; 4(10): 1335-1343, 2018 10 01.
Article en En | MEDLINE | ID: mdl-29902286
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Tamoxifeno / Neoplasias de la Mama / Receptores de Estrógenos / Posmenopausia / Letrozol Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Middle aged Idioma: En Revista: JAMA Oncol Año: 2018 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Tamoxifeno / Neoplasias de la Mama / Receptores de Estrógenos / Posmenopausia / Letrozol Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Middle aged Idioma: En Revista: JAMA Oncol Año: 2018 Tipo del documento: Article País de afiliación: Australia